Moleac at the 3rd European Stroke Organisation Conference

By May 18, 2017News

Moleac team just attended the 3rd European Stroke Organisation Conference (ESOC) in Prague, Czech Republic in the past 3 days.

Research on NeuroAiD remains highly active and international conferences are great opportunities to present the latest findings from clinical trials and studies. This year, in addition to new data on the benefits for post-stroke recovery, clinicians presented new insights from NeuroAiD studies targeted at stroke victims with high potential for recovery:

  • Comparison of Long-term Spontaneous Functional Recovery and Response to Treatment with MLC601 between Cortical and Non-cortical strokes – The CHIMES-E study
  • Synergistic Effect of Combining MLC601 and Rehabilitation on Post-stroke Recovery – The CHIMES Study
  • Targeting Stroke Patients with a Higher Potential of Long-term Benefit from Treatment: Insights from the CHIMES-E Study

On 16th May, we were overwhelmed to have a full house of more than 150 people attending our dinner symposium at InterContinental Prague.  It was our honour to listen to presentations from world-class leaders in stroke research:

  • Prof. Pamela Duncan from the United States detailed her extensive research on capturing outcomes after stroke.
  • Prof. Christopher Chen from Singapore, one of the principal investigators of NeuroAiD’s landmark studies CHIMES and CHIMES-E studies, presented the long term benefits of NeuroAiD on post-stroke recovery.
  • Dr. Boutarene and Dr. Bouabdallah from Algeria presented the observational study they conducted on NeuroAiD with NeST Registry.

We look forward to replicating such a success next year.